NOVO NORDISK INC. for NOVO NORDISK INC.
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Issues related to diabetes, obesity, hemophilia, and growth deficiency.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON New | — |
| TRICIA BROOKS New | — |
| AMANDA MAKKI New | — |
| SARAH ELIZABETH NORDSTROM New | — |
| LAUREN ELIZABETH SEMENIUK New | — |
| AMY WOTRING New | — |
Veterans VET
Issues related to diabetes, obesity, hemophilia, and growth deficiency.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON New | — |
| TRICIA BROOKS New | — |
| AMANDA MAKKI New | — |
| SARAH ELIZABETH NORDSTROM New | — |
| LAUREN ELIZABETH SEMENIUK New | — |
| AMY WOTRING New | — |
Health Issues HCR
Issues related to diabetes, obesity, hemophilia, and growth deficiency.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON New | — |
| TRICIA BROOKS New | — |
| AMANDA MAKKI New | — |
| SARAH ELIZABETH NORDSTROM New | — |
| LAUREN ELIZABETH SEMENIUK New | — |
| AMY WOTRING New | — |
Medicare/Medicaid MMM
Issues related to diabetes, obesity, hemophilia, and growth deficiency.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON New | — |
| TRICIA BROOKS New | — |
| AMANDA MAKKI New | — |
| SARAH ELIZABETH NORDSTROM New | — |
| LAUREN ELIZABETH SEMENIUK New | — |
| AMY WOTRING New | — |
Pharmacy PHA
Issues related to diabetes, obesity, hemophilia, and growth deficiency.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON New | — |
| TRICIA BROOKS New | — |
| AMANDA MAKKI New | — |
| SARAH ELIZABETH NORDSTROM New | — |
| LAUREN ELIZABETH SEMENIUK New | — |
| AMY WOTRING New | — |
Defense DEF
Issues related to diabetes, obesity, hemophilia, and growth deficiency.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON New | — |
| TRICIA BROOKS New | — |
| AMANDA MAKKI New | — |
| SARAH ELIZABETH NORDSTROM New | — |
| LAUREN ELIZABETH SEMENIUK New | — |
| AMY WOTRING New | — |
Taxation/Internal Revenue Code TAX
Issues related to diabetes, obesity, hemophilia, and growth deficiency.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON New | — |
| TRICIA BROOKS New | — |
| AMANDA MAKKI New | — |
| SARAH ELIZABETH NORDSTROM New | — |
| LAUREN ELIZABETH SEMENIUK New | — |
| AMY WOTRING New | — |
Copyright/Patent/Trademark CPT
Issues related to diabetes, obesity, hemophilia, and growth deficiency.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON New | — |
| TRICIA BROOKS New | — |
| AMANDA MAKKI New | — |
| SARAH ELIZABETH NORDSTROM New | — |
| LAUREN ELIZABETH SEMENIUK New | — |
| AMY WOTRING New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| NOVO NORDISK FONDEN (ULTIMATE PARENT COMPANY). | Denmark | Denmark | 100.0% | — |
| NOVO A/S (OWNS 26.5% OF NN A/S). | Denmark | Denmark | 26.0% | — |
| REGISTRANT IS A WHOLLY-OWNED SUBSIDIARY OF NOVO NORDISK US WHICH IS WHOLLY-OWNED BY NOVO NORDISK A/S. | Denmark | Denmark | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.